DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Pilocarpine Hydrochloride is a drug marketed by Akorn Inc, Somerset Theraps Llc, Aurobindo Pharma Ltd, Impax Labs, Innogenix, Lannett Co Inc, and Perrigo Pharma Intl. and is included in seven NDAs.
The generic ingredient in PILOCARPINE HYDROCHLORIDE is pilocarpine hydrochloride. There are twelve drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the pilocarpine hydrochloride profile page.
A generic version of PILOCARPINE HYDROCHLORIDE was approved as pilocarpine hydrochloride by PERRIGO PHARMA INTL on November 16th, 2004.
Recent Clinical Trials for PILOCARPINE HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
|Universidad de Murcia||Phase 1|
|Montefiore Medical Center||Phase 3|
|Maastricht University Medical Center||Early Phase 1|